Final results of the Minnie Pearl Cancer Research Network first-line trial of weekly paclitaxel/carboplatin/trastuzumab in metastatic breast cancer.

被引：0
|
作者：
Yardley, DA
Greco, FA
Hainsworth, JD
Houston, GA
Broome, CM
Bramham, J
Patton, JF
Thompson, DS
Erland, JS
White, MB
Burris, HA
机构：
[1] Sarah Cannon Canc Ctr Tennessee Oncol, PLLC, Nashville, TN USA
[2] Jackson Oncol Associates, Jackson, MS USA
[3] No Virginia Oncol Grp PC, Fairfax, VA USA
[4] Graves Gilbert Clin, Bowling Green, KY USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2002年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
439
引用
收藏
页码：S113 / S113
页数：1
相关论文
共 50 条
  • [21] Weekly one-hour paclitaxel as first-line chemotherapy for metastatic breast cancer
    Wist, EA
    Sommer, HH
    Ostenstad, B
    Risberg, T
    Fjæstad, K
    ACTA ONCOLOGICA, 2004, 43 (01) : 11 - 14
  • [22] Paclitaxel and carboplatin as first-line chemotherapy for advanced breast cancer
    Fountzilas, G
    Athanassiades, A
    Papadimitriou, V
    Dimopoulos, MA
    Bafaloukos, D
    Aravantinos, G
    Nicolaides, C
    Kalofonos, HR
    Papakostas, P
    Xiros, N
    Razi, E
    ONCOLOGY-NEW YORK, 1998, 12 (01): : 45 - 48
  • [23] Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: Final results of a minnie pearl cancer research network phase II trial
    Meluch, AA
    Greco, FA
    Gray, JR
    Thomas, M
    Sutton, VM
    Davis, JL
    Kalman, LA
    Shaffer, DW
    Yost, K
    Rinaldi, DA
    Hainsworth, JD
    CANCER JOURNAL, 2003, 9 (04): : 251 - 260
  • [24] Results of first-line weekly paclitaxel (P) plus gemcitabine (G) in metastatic breast cancer (MBC): An AERO phase II trial
    Mousseau, M.
    Serin, D.
    Petit, T.
    Priou, F.
    Zelek, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [25] Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: A Minnie Pearl Cancer Research Network phase II trial
    Hainsworth, JD
    Burris, HA
    Yardley, DA
    Bradof, JE
    Grimaldi, M
    Kalman, LA
    Sullivan, T
    Baker, M
    Erland, JB
    Greco, FA
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (15) : 3500 - 3505
  • [26] Final analysis of weekly paclitaxel and weekly carboplatin (P) as first-line chemotherapy in 130 patients with advanced ovarian cancer (AOC).
    Sehouli, J
    Oskay-Oezcelik, G
    Camara, O
    Keil, E
    Ledwon, P
    Diedrich, K
    Elling, D
    Gebauer, G
    Christiansen, C
    Ortmann, O
    Lichtenegger, W
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 468S - 468S
  • [27] Tolerability of carboplatin, paclitaxel and erlotinib as first-line treatment of ovarian cancer.
    Blank, SV
    Curtin, JP
    Goldman, NA
    Fusco, E
    Lesko, Z
    Hochster, H
    Runowicz, CD
    Wadler, S
    Muggia, FM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 467S - 467S
  • [28] Vinorelbine (VNB) and paclitaxel (PTX) as first-line chemotherapy (FLC) in metastatic breast cancer (MBC): Final results
    Acuna, LR
    Langhi, M
    Perez, J
    Leone, B
    Machiavelli, M
    Lacava, J
    Vallejo, C
    Romero, A
    Fasce, H
    Ortiz, E
    Grasso, S
    Amato, S
    Rodriguez, R
    Barbieri, M
    Acuna, JR
    ANNALS OF ONCOLOGY, 1998, 9 : 20 - 20
  • [29] IMP321 and weekly paclitaxel as first-line chemoimmunotherapy for metastatic breast cancer (MBC)
    Triebel, F.
    Brignone, C.
    Grygar, C.
    Marcu, M.
    Gutierez, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [30] IMP321 and Weekly Paclitaxel as First-line Chemoimmunotherapy for Metastatic Breast Cancer (MBC)
    Triebel, Frederic
    Brignone, Chrystelle
    Maya, Gutierrez
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (09) : 952 - 953
12345